Singapore markets close in 7 hours 57 minutes

Straits Times Index
3,292.93
-3.96(-0.12%)
Nikkei
38,236.07
-38.03(-0.10%)
Hang Seng
18,475.92
+268.82(+1.48%)
FTSE 100
8,213.49
+41.34(+0.51%)
Bitcoin USD
64,272.79
+734.95(+1.16%)
CMC Crypto 200
1,334.56
+57.58(+4.51%)

AGIO Nov 2024 40.000 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

1.7000

0.0000

(0.00%)

As of 01:42PM EDT. Market open.

Simply Wall St.
Earnings Beat: Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
Investors in Agios Pharmaceuticals, Inc. ( NASDAQ:AGIO ) had a good week, as its shares rose 9.7% to close at US$34.54...
Zacks
Agios (AGIO) Q1 Earnings Surpass, Sales Miss Estimates
Agios (AGIO) reports mixed earnings results for first-quarter 2024. Though sales miss the mark, revenues from its sole marketed drug, Pyrukynd, rise sequentially and on a yearly basis.
Insider Monkey
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q1 2024 Earnings Call Transcript
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q1 2024 Earnings Call Transcript May 2, 2024 Agios Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, and welcome to Agios’ First Quarter 2024 Conference Call. [Operator Instructions] Please be advised that […]